The PE Ratio as of November 2024 (TTM) for NeuroBo Pharmaceuticals, Inc. (NRBO) is -0.55

According to NeuroBo Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.55. This represents a change of -40.52% compared to the average of -0.92 of the last 4 quarters.

NeuroBo Pharmaceuticals, Inc. (NRBO) Historical PE Ratio (quarterly & annually)

How has NRBO PE Ratio performed in the past?

The mean historical PE Ratio of NeuroBo Pharmaceuticals, Inc. over the last ten years is -134.48. The current -0.55 PE Ratio has changed -59.10% with respect to the historical average. Over the past ten years (40 quarters), NRBO's PE Ratio was at its highest in in the December 2022 quarter at 4.59. The PE Ratio was at its lowest in in the June 2016 quarter at -121.45.

NeuroBo Pharmaceuticals, Inc. (NRBO) PE Ratio by Quarter and Year

Discovering the peaks and valleys of NeuroBo Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NeuroBo Pharmaceuticals, Inc. (NRBO) Average PE Ratio

How has NRBO PE Ratio performed in the past?

The current PE Ratio of NeuroBo Pharmaceuticals, Inc. (NRBO) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NeuroBo Pharmaceuticals, Inc. (NRBO) PE Ratio vs. Peers

How is NRBO’s PE Ratio compared to its peers?

NeuroBo Pharmaceuticals, Inc.’s PE Ratio is less than Allarity Therapeutics, Inc. (-0.10), greater than Hillstream BioPharma, Inc. (-0.99), greater than Virax Biolabs Group Limited (-0.67), less than Quoin Pharmaceuticals, Ltd. (-0.33), greater than Kiromic BioPharma, Inc. (-1.34), less than Biodexa Pharmaceuticals Plc (-0.18), greater than Zura Bio Limited (-5.60), less than Phio Pharmaceuticals Corp. (-0.33), greater than Sonnet BioTherapeutics Holdings, Inc. (-1.88), greater than 180 Life Sciences Corp. (-0.71), greater than Cardio Diagnostics Holdings, Inc. (-0.79), less than Blue Water Vaccines, Inc. (-0.26), less than PaxMedica, Inc. Common Stock (-0.04), less than Revelation Biosciences, Inc. (-0.13), less than Kiora Pharmaceuticals, Inc. (2.56),

Build a custom stock screener for NeuroBo Pharmaceuticals, Inc. (NRBO) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NeuroBo Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NeuroBo Pharmaceuticals, Inc. (NRBO) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NeuroBo Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.